Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations - Reuters

Reuters | June 29, 2020, 7:13 a.m. | Original
Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nations Reuters
St. Louis couple threatens protesters with guns outside their home - Reuters UK Pandemic leads to six months of global market mayhem - Reuters